![healthbook ASCO 2023 Newsroom. Video: Personal Highlights from Dr Jason Westin.](/images/healthbook_ASCO_2023.png)
Focused on the Cure
Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everything we do, from early research to product development.
![Focused on the Cure](/img/focused-on-the-cure-homepage.jpg)
Videos
Your local cell therapy team
Yescarta® resources
Cell Therapy Pipeline
![Virtual hospital](/img/ct-virtual-hospital-icon.png)
Virtual Hospital
Publications
CAR T Centers
![Podcasts icon](/img/icons/podcast.png)
Podcasts
Disease awareness
Zuma-1 Study
![healthbook ASCO 2023 Newsroom. Video: Personal Highlights from Dr Jason Westin.](/images/healthbook_ASCO_2023.png)
healthbook ASCO 2023 Newsroom: Personal Highlights Dr Jason Westin
Dr Jason Westin summarizes data from the ZUMA-7 trial, which he presented at the 2023 ASCO Annual Meeting. Oral presentation LBA107. ZUMA‑7. Westin J et al.
Source: healthbook ASCO 2023 Newsroom. Video: Personal Highlights from Dr Jason Westin.